ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Gross of the placeholder expense ratio and trading costs · not investor results
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1MA | MASTERCARD INC | Financial Services | $568.53B | 13.51% |
2TMO | THERMO FISHER SCIENTIFIC INC | Healthcare | $259.15B | 6.16% |
3CRWD | CROWDSTRIKE HOLDINGS INC | Technology | $235.37B | 5.59% |
4GEV | GE VERNOVA INC | Utilities | $216.64B | 5.15% |
5KLAC | KLA CORP | Technology | $204.96B | 4.87% |
6DHR | DANAHER CORP | Healthcare | $163.33B | 3.88% |
7MCK | MCKESSON CORP | Healthcare | $124.35B | 2.95% |
8ADP | AUTOMATIC DATA PROCESSING INC | Industrials | $121.55B | 2.89% |
9BKNG | BOOKING HOLDINGS INC | Consumer Cyclical | $119.88B | 2.85% |
10ABNB | AIRBNB INC | Consumer Cyclical | $108.09B | 2.57% |
11MMM | 3M CO | Industrials | $96.24B | 2.29% |
12FTNT | FORTINET INC | Technology | $95.17B | 2.26% |
13TT | TRANE TECHNOLOGIES PLC | Industrials | $92.82B | 2.21% |
14COR | CENCORA INC | Healthcare | $66.67B | 1.58% |
15CAH | CARDINAL HEALTH INC | Healthcare | $64.29B | 1.53% |
16EW | EDWARDS LIFESCIENCES CORP | Healthcare | $60.84B | 1.45% |
17ADSK | AUTODESK INC | Technology | $54.23B | 1.29% |
18KEYS | KEYSIGHT TECHNOLOGIES INC | Technology | $51.79B | 1.23% |
19A | AGILENT TECHNOLOGIES INC | Healthcare | $48.78B | 1.16% |
20PYPL | PAYPAL HOLDINGS INC | Financial Services | $48.43B | 1.15% |
21ROP | ROPER TECHNOLOGIES INC | Technology | $47.33B | 1.12% |
22STT | STATE STREET CORP | Financial Services | $47.26B | 1.12% |
23COHR | COHERENT CORP | Technology | $45.71B | 1.09% |
24ROK | ROCKWELL AUTOMATION INC | Industrials | $44.89B | 1.07% |
25TER | TERADYNE INC | Technology | $41.18B | 0.98% |
26TEAM | ATLASSIAN CORP | Technology | $38.35B | 0.91% |
27GEHC | GE HEALTHCARE TECHNOLOGIES INC | Healthcare | $37.00B | 0.88% |
28RBLX | ROBLOX CORP | Communication Services | $36.80B | 0.87% |
29MTD | METTLER TOLEDO INTERNATIONAL INC | Healthcare | $34.43B | 0.82% |
30ILMN | ILLUMINA INC | Healthcare | $31.68B | 0.75% |
31EXPE | EXPEDIA GROUP INC | Consumer Cyclical | $30.95B | 0.74% |
32DXCM | DEXCOM INC | Healthcare | $30.35B | 0.72% |
33CPAY | CORPAY INC | Technology | $29.17B | 0.69% |
34WST | WEST PHARMACEUTICAL SERVICES INC | Healthcare | $28.65B | 0.68% |
35VLTO | VERALTO CORP | Industrials | $28.57B | 0.68% |
36VRSN | VERISIGN INC | Technology | $28.03B | 0.67% |
37CPNG | COUPANG INC | Consumer Cyclical | $27.40B | 0.65% |
38ENTG | ENTEGRIS INC | Technology | $23.41B | 0.56% |
39RBRK | RUBRIK INC | Technology | $22.88B | 0.54% |
40SYM | SYMBOTIC INC | Industrials | $21.43B | 0.51% |
41FTV | FORTIVE CORP | Technology | $20.20B | 0.48% |
42MEDP | MEDPACE HOLDINGS INC | Healthcare | $18.37B | 0.44% |
43RVTY | REVVITY INC | Healthcare | $17.53B | 0.42% |
44CRCL | CIRCLE INTERNET GROUP INC | Financial Services | $16.37B | 0.39% |
45W | WAYFAIR INC | Consumer Cyclical | $15.25B | 0.36% |
46BBIO | BRIDGEBIO PHARMA INC | Healthcare | $15.23B | 0.36% |
47CSL | CARLISLE COMPANIES INC | Industrials | $15.17B | 0.36% |
48DOCU | DOCUSIGN INC | Technology | $14.98B | 0.36% |
49MKSI | MKS INC | Technology | $14.98B | 0.36% |
50MANH | MANHATTAN ASSOCIATES INC | Technology | $14.89B | 0.35% |
51BAX | BAXTER INTERNATIONAL INC | Healthcare | $13.32B | 0.32% |
52TRMB | TRIMBLE INC | Technology | $12.80B | 0.30% |
53IT | GARTNER INC | Technology | $12.04B | 0.29% |
54ALGN | ALIGN TECHNOLOGY INC | Healthcare | $11.77B | 0.28% |
55PAYC | PAYCOM SOFTWARE INC | Technology | $11.21B | 0.27% |
56AVTR | AVANTOR INC | Basic Materials | $10.58B | 0.25% |
57HUBS | HUBSPOT INC | Technology | $10.54B | 0.25% |
58ONTO | ONTO INNOVATION INC | Technology | $10.29B | 0.24% |
59BIO | BIO-RAD LABORATORIES INC | Healthcare | $9.96B | 0.24% |
60OSCR | OSCAR HEALTH INC | Healthcare | $9.92B | 0.24% |
61HNGE | HINGE HEALTH INC | Healthcare | $9.83B | 0.23% |
62PCTY | PAYLOCITY HOLDING CORP | Technology | $9.30B | 0.22% |
63BRKR | BRUKER CORP | Healthcare | $9.21B | 0.22% |
64WMS | ADVANCED DRAINAGE SYSTEMS INC | Industrials | $9.12B | 0.22% |
65ATR | APTARGROUP INC | Healthcare | $8.98B | 0.21% |
66CGNX | COGNEX CORP | Technology | $8.55B | 0.20% |
67RAL | RALLIANT CORP | Technology | $7.82B | 0.19% |
68TXG | 10X GENOMICS INC | Healthcare | $7.77B | 0.18% |
69RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | $7.62B | 0.18% |
70ETSY | ETSY INC | Consumer Cyclical | $7.61B | 0.18% |
71AXSM | AXSOME THERAPEUTICS INC | Healthcare | $7.59B | 0.18% |
72DBX | DROPBOX INC | Technology | $7.49B | 0.18% |
73YOU | CLEAR SECURE INC | Technology | $7.46B | 0.18% |
74DUOL | DUOLINGO INC | Technology | $7.43B | 0.18% |
75TTD | TRADE DESK INC | Technology | $7.32B | 0.17% |
76AWI | ARMSTRONG WORLD INDUSTRIES INC | Industrials | $7.31B | 0.17% |
77IMVT | IMMUNOVANT INC | Healthcare | $7.25B | 0.17% |
78CVLT | COMMVAULT SYSTEMS INC | Technology | $6.80B | 0.16% |
79MP | MP MATERIALS CORP | Basic Materials | $6.68B | 0.16% |
80FLR | FLUOR CORP | Industrials | $6.35B | 0.15% |
81LYFT | LYFT INC | Technology | $6.28B | 0.15% |
82CTVA | CORTEVA INC | Basic Materials | $6.13B | 0.15% |
83TFX | TELEFLEX INC | Healthcare | $6.07B | 0.14% |
84QLYS | QUALYS INC | Technology | $6.04B | 0.14% |
85KVYO | KLAVIYO INC | Technology | $6.01B | 0.14% |
86BOX | BOX INC | Technology | $5.99B | 0.14% |
87NPO | ENPRO INC | Industrials | $5.90B | 0.14% |
88ST | SENSATA TECHNOLOGIES HOLDING PLC | Technology | $5.74B | 0.14% |
89VNT | VONTIER CORP | Technology | $5.73B | 0.14% |
90PTCT | PTC THERAPEUTICS INC | Healthcare | $5.29B | 0.13% |
91TPC | TUTOR PERINI CORP | Industrials | $5.27B | 0.13% |
92SRRK | SCHOLAR ROCK HOLDING CORP | Healthcare | $5.27B | 0.13% |
93PEGA | PEGASYSTEMS INC | Technology | $5.24B | 0.12% |
94LQDA | LIQUIDIA CORP | Healthcare | $5.24B | 0.12% |
95LIVN | LIVANOVA PLC | Healthcare | $4.97B | 0.12% |
96SITE | SITEONE LANDSCAPE SUPPLY INC | Industrials | $4.86B | 0.12% |
97MIR | MIRION TECHNOLOGIES INC | Industrials | $4.41B | 0.10% |
98BMI | BADGER METER INC | Technology | $4.39B | 0.10% |
99TENB | TENABLE HOLDINGS INC | Technology | $4.29B | 0.10% |
100ITRI | ITRON INC | Technology | $4.23B | 0.10% |
101MGNI | MAGNITE INC | Communication Services | $4.21B | 0.10% |
102LION | LIONSGATE STUDIOS CORP | Communication Services | $4.20B | 0.10% |
103BANF | BANCFIRST CORP | Financial Services | $3.99B | 0.09% |
104NVST | ENVISTA HOLDINGS CORP | Healthcare | $3.95B | 0.09% |
105APPN | APPIAN CORP | Technology | $3.94B | 0.09% |
106TARS | TARSUS PHARMACEUTICALS INC | Healthcare | $3.79B | 0.09% |
107WK | WORKIVA INC | Technology | $3.73B | 0.09% |
108BFH | BREAD FINANCIAL HOLDINGS INC | Financial Services | $3.72B | 0.09% |
109INTA | INTAPP INC | Technology | $3.52B | 0.08% |
110AVPT | AVEPOINT INC | Technology | $3.44B | 0.08% |
111FRSH | FRESHWORKS INC | Technology | $3.32B | 0.08% |
112WRBY | WARBY PARKER INC | Healthcare | $3.32B | 0.08% |
113USLM | UNITED STATES LIME & MINERALS INC | Basic Materials | $3.28B | 0.08% |
114IRTC | IRHYTHM HOLDINGS INC | Healthcare | $3.15B | 0.07% |
115TDC | TERADATA CORP | Technology | $3.12B | 0.07% |
116CALM | CAL-MAINE FOODS INC | Consumer Defensive | $3.00B | 0.07% |
117TNET | TRINET GROUP INC | Industrials | $2.99B | 0.07% |
118LUNR | INTUITIVE MACHINES INC | Industrials | $2.98B | 0.07% |
119VERX | VERTEX INC | Technology | $2.88B | 0.07% |
120PRCH | PORCH GROUP INC | Technology | $2.83B | 0.07% |
121RSI | RUSH STREET INTERACTIVE INC | Consumer Cyclical | $2.72B | 0.06% |
122PTON | PELOTON INTERACTIVE INC | Consumer Cyclical | $2.47B | 0.06% |
123NWL | NEWELL BRANDS INC | Consumer Defensive | $2.45B | 0.06% |
124BLKB | BLACKBAUD INC | Technology | $2.41B | 0.06% |
125LIND | LINDBLAD EXPEDITIONS HOLDINGS INC | Consumer Cyclical | $2.24B | 0.05% |
126PVLA | PALVELLA THERAPEUTICS INC | Healthcare | $2.24B | 0.05% |
127ASAN | ASANA INC | Technology | $2.21B | 0.05% |
128AMPL | AMPLITUDE INC | Technology | $2.21B | 0.05% |
129LEU | CENTRUS ENERGY CORP | Energy | $2.14B | 0.05% |
130COHU | COHU INC | Technology | $2.13B | 0.05% |
131REPL | REPLIMUNE GROUP INC | Healthcare | $2.08B | 0.05% |
132WU | WESTERN UNION CO | Financial Services | $2.08B | 0.05% |
133IDT | IDT CORP | Communication Services | $2.06B | 0.05% |
134ESTA | ESTABLISHMENT LABS HOLDINGS INC | Healthcare | $2.05B | 0.05% |
135AEHR | AEHR TEST SYSTEMS | Technology | $2.00B | 0.05% |
136NSP | INSPERITY INC | Industrials | $1.90B | 0.05% |
137MQ | MARQETA INC | Technology | $1.87B | 0.04% |
138XRAY | DENTSPLY SIRONA INC | Healthcare | $1.83B | 0.04% |
139REAL | THEREALREAL INC | Consumer Cyclical | $1.78B | 0.04% |
140BFLY | BUTTERFLY NETWORK INC | Healthcare | $1.78B | 0.04% |
141SLS | SELLAS LIFE SCIENCES GROUP INC | Healthcare | $1.62B | 0.04% |
142HYMC | HYCROFT MINING HOLDING CORP | Basic Materials | $1.58B | 0.04% |
143CXM | SPRINKLR INC | Technology | $1.54B | 0.04% |
144SEDG | SOLAREDGE TECHNOLOGIES INC | Technology | $1.50B | 0.04% |
145NVAX | NOVAVAX INC | Healthcare | $1.45B | 0.03% |
146ALNT | ALLIENT INC | Technology | $1.44B | 0.03% |
147KRSA | KORSANA BIOSCIENCES INC | Healthcare | $1.42B | 0.03% |
148LQDT | LIQUIDITY SERVICES INC | Consumer Cyclical | $1.41B | 0.03% |
149OCUL | OCULAR THERAPEUTIX INC | Healthcare | $1.38B | 0.03% |
150NVCR | NOVOCURE LTD | Healthcare | $1.37B | 0.03% |
151IBTA | IBOTTA INC | Technology | $1.36B | 0.03% |
152PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | $1.35B | 0.03% |
153STAA | STAAR SURGICAL CO | Healthcare | $1.34B | 0.03% |
154SECZ | SECURITIZE CORP | Technology | $1.30B | 0.03% |
155URGN | UROGEN PHARMA LTD | Healthcare | $1.29B | 0.03% |
156DMC | DEL MONTE CORP | Consumer Defensive | $1.29B | 0.03% |
157CMPS | COMPASS PATHWAYS PLC | Healthcare | $1.29B | 0.03% |
158INBX | INHIBRX BIOSCIENCES INC | Healthcare | $1.29B | 0.03% |
159INOD | INNODATA INC | Technology | $1.25B | 0.03% |
160UPWK | UPWORK INC | Industrials | $1.24B | 0.03% |
161DRTS | ALPHA TAU MEDICAL LTD | Healthcare | $1.23B | 0.03% |
162ANRO | ALTO NEUROSCIENCE INC | Healthcare | $1.23B | 0.03% |
163VOR | VOR BIOPHARMA INC | Healthcare | $1.19B | 0.03% |
164FRNM | FREENOME INC | Healthcare | $1.14B | 0.03% |
165IRMD | IRADIMED CORP | Healthcare | $1.09B | 0.03% |
166MYE | MYERS INDUSTRIES INC | Consumer Cyclical | $1.07B | 0.03% |
167VSTM | VERASTEM INC | Healthcare | $1.06B | 0.03% |
168CBLL | CERIBELL INC | Healthcare | $1.02B | 0.02% |
169AIP | ARTERIS INC | Technology | $1.00B | 0.02% |
170TRNS | TRANSCAT INC | Industrials | $1.00B | 0.02% |
171EVER | EVERQUOTE INC | Communication Services | $989M | 0.02% |
172WLFC | WILLIS LEASE FINANCE CORP | Industrials | $981M | 0.02% |
173WINA | WINMARK CORP | Consumer Cyclical | $967M | 0.02% |
174SWIM | LATHAM GROUP INC | Industrials | $964M | 0.02% |
175BV | BRIGHTVIEW HOLDINGS INC | Industrials | $935M | 0.02% |
176BVS | BIOVENTUS INC | Healthcare | $915M | 0.02% |
177PUBM | PUBMATIC INC | Technology | $872M | 0.02% |
178TRIP | TRIPADVISOR INC | Consumer Cyclical | $855M | 0.02% |
179MLAB | MESA LABORATORIES INC | Technology | $760M | 0.02% |
180DSP | VIANT TECHNOLOGY INC | Technology | $760M | 0.02% |
181FEIM | FREQUENCY ELECTRONICS INC | Technology | $758M | 0.02% |
182YEXT | YEXT INC | Technology | $757M | 0.02% |
183BBSI | BARRETT BUSINESS SERVICES INC | Industrials | $744M | 0.02% |
184CTKB | CYTEK BIOSCIENCES INC | Healthcare | $722M | 0.02% |
185CASS | CASS INFORMATION SYSTEMS INC | Industrials | $708M | 0.02% |
186KRT | KARAT PACKAGING INC | Consumer Cyclical | $707M | 0.02% |
187NVCT | NUVECTIS PHARMA INC | Healthcare | $696M | 0.02% |
188KURA | KURA ONCOLOGY INC | Healthcare | $683M | 0.02% |
189SPT | SPROUT SOCIAL INC | Technology | $678M | 0.02% |
190QMCO | QUANTUM CORP | Technology | $658M | 0.02% |
191CADL | CANDEL THERAPEUTICS INC | Healthcare | $642M | 0.02% |
192SGHT | SIGHT SCIENCES INC | Healthcare | $611M | 0.01% |
193SRZN | SURROZEN INC | Healthcare | $604M | 0.01% |
194AVR | ANTERIS TECHNOLOGIES GLOBAL CORP | Healthcare | $571M | 0.01% |
195SENS | SENSEONICS HOLDINGS INC | Healthcare | $550M | 0.01% |
196PAYS | PAYSIGN INC | Technology | $540M | 0.01% |
197CBIO | CRESCENT BIOPHARMA INC | Healthcare | $534M | 0.01% |
198RMNI | RIMINI STREET INC | Technology | $518M | 0.01% |
199RCEL | AVITA MEDICAL INC | Healthcare | $509M | 0.01% |
200PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | $506M | 0.01% |
201ANGO | ANGIODYNAMICS INC | Healthcare | $504M | 0.01% |
202GNE | GENIE ENERGY LTD | Utilities | $494M | 0.01% |
203GRPN | GROUPON INC | Communication Services | $489M | 0.01% |
204OBIO | ORCHESTRA BIOMED HOLDINGS INC | Healthcare | $484M | 0.01% |
205CARL | CARLSMED INC | Healthcare | $474M | 0.01% |
206APXT | APEX TREASURY CORP | Financial Services | $469M | 0.01% |
207ZIP | ZIPRECRUITER INC | Industrials | $461M | 0.01% |
208SI | SHOULDER INNOVATIONS INC | Healthcare | $441M | 0.01% |
209PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | $423M | 0.01% |
210TECX | TECTONIC THERAPEUTIC INC | Healthcare | $420M | 0.01% |
211MASS | 908 DEVICES INC | Healthcare | $407M | 0.01% |
212FENC | FENNEC PHARMACEUTICALS INC | Healthcare | $382M | 0.01% |
213ALUB | ALUSSA ENERGY ACQUISITION CORP II | Financial Services | $366M | 0.01% |
214EMBC | EMBECTA CORP | Healthcare | $364M | 0.01% |
215TMCI | TREACE MEDICAL CONCEPTS INC | Healthcare | $350M | 0.01% |
216MKTW | MARKETWISE INC | Technology | $350M | 0.01% |
217CBNA | CHAIN BRIDGE BANCORP INC | Financial Services | $344M | 0.01% |
218EVOX | EVOLUTION GLOBAL ACQUISITION CORP | Financial Services | $325M | 0.01% |
219RNGT | RANGE CAPITAL ACQUISITION CORP II | Financial Services | $320M | 0.01% |
220BNTC | BENITEC BIOPHARMA INC | Healthcare | $317M | 0.01% |
221CV | CAPSOVISION INC | Healthcare | $314M | 0.01% |
222SMTI | SANARA MEDTECH INC | Healthcare | $299M | 0.01% |
223HCAC | HALL CHADWICK ACQUISITION CORP | Financial Services | $298M | 0.01% |
224GFUZ | GENERAL FUSION GROUP LTD | Industrials | $288M | 0.01% |
225UCFI | CN HEALTHY FOOD TECH GROUP CORP | Consumer Defensive | $288M | 0.01% |
226ENHA | ENHANCED GROUP INC | Consumer Defensive | $279M | 0.01% |
227ALCO | ALICO INC | Consumer Defensive | $276M | 0.01% |
228OPTX | SYNTEC OPTICS HOLDINGS INC | Technology | $274M | 0.01% |
229DNMX | DYNAMIX CORP III | Financial Services | $272M | 0.01% |
230QTTB | Q32 BIO INC | Healthcare | $264M | 0.01% |
231FACT | FACT II ACQUISITION CORP | Industrials | $263M | 0.01% |
232MTRX | MATRIX SERVICE CO | Industrials | $260M | 0.01% |
233ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $243M | 0.01% |
234IGAC | INVEST GREEN ACQUISITION CORP | Financial Services | $242M | 0.01% |
235TDWD | TAILWIND 20 ACQUISITION CORP | Financial Services | $239M | 0.01% |
236OFLX | OMEGA FLEX INC | Industrials | $237M | 0.01% |
237DYOR | INSIGHT DIGITAL PARTNERS II | Financial Services | $234M | 0.01% |
238UTMD | UTAH MEDICAL PRODUCTS INC | Healthcare | $234M | 0.01% |
239RXST | RXSIGHT INC | Healthcare | $226M | 0.01% |
240DTIL | PRECISION BIOSCIENCES INC | Healthcare | $225M | 0.01% |
241GLSI | GREENWICH LIFESCIENCES INC | Healthcare | $224M | 0.01% |
242AMWL | AMERICAN WELL CORP | Healthcare | $207M | 0.00% |
243CMT | CORE MOLDING TECHNOLOGIES INC | Basic Materials | $207M | 0.00% |
244FIRY | FIRY INC | Communication Services | $200M | 0.00% |
245KROS | KEROS THERAPEUTICS INC | Healthcare | $198M | 0.00% |
246RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | $194M | 0.00% |
247IMXI | INTERNATIONAL MONEY EXPRESS INC | Technology | $193M | 0.00% |
248INTT | INTEST CORP | Technology | $190M | 0.00% |
249LMNR | LIMONEIRA CO | Consumer Defensive | $185M | 0.00% |
250ANIK | ANIKA THERAPEUTICS INC | Healthcare | $185M | 0.00% |
251RAIL | FREIGHTCAR AMERICA INC | Industrials | $175M | 0.00% |
252FC | FRANKLIN COVEY CO | Industrials | $168M | 0.00% |
253FORR | FORRESTER RESEARCH INC | Industrials | $166M | 0.00% |
254LKSP | LAKE SUPERIOR ACQUISITION CORP | Financial Services | $162M | 0.00% |
255LAFA | LAFAYETTE ACQUISITION CORP | Financial Services | $160M | 0.00% |
256EGAN | EGAIN CORP | Technology | $160M | 0.00% |
257STRO | SUTRO BIOPHARMA INC | Healthcare | $159M | 0.00% |
258AP | AMPCO PITTSBURGH CORP | Industrials | $159M | 0.00% |
259INGN | INOGEN INC | Healthcare | $146M | 0.00% |
260ALMU | AELUMA INC | Technology | $146M | 0.00% |
261HURC | HURCO COMPANIES INC | Industrials | $135M | 0.00% |
262CUE | CUE BIOPHARMA INC | Healthcare | $127M | 0.00% |
263SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $123M | 0.00% |
264IMUX | IMMUNIC INC | Healthcare | $106M | 0.00% |
265SKIN | SKINHEALTH SYSTEMS INC | Consumer Defensive | $104M | 0.00% |
266KEQU | KEWAUNEE SCIENTIFIC CORP | Consumer Cyclical | $104M | 0.00% |
267FVN | FUTURE VISION II ACQUISITION CORP | Financial Services | $98M | 0.00% |
268LGL | LGL GROUP INC | Technology | $88M | 0.00% |
269RLYB | RALLYBIO CORP | Healthcare | $84M | 0.00% |
270VTVT | VTV THERAPEUTICS INC | Healthcare | $83M | 0.00% |
271NRXS | NEURAXIS INC | Healthcare | $82M | 0.00% |
272WTG | WINTERGREEN ACQUISITION CORP | Financial Services | $79M | 0.00% |
273NRDY | NERDY INC | Technology | $76M | 0.00% |
274MRDN | MERIDIAN HOLDINGS INC | Communication Services | $73M | 0.00% |
275NTRB | NUTRIBAND INC | Healthcare | $73M | 0.00% |
276ALIS | CALISA ACQUISITION CORP | Financial Services | $71M | 0.00% |
277GOSS | GOSSAMER BIO INC | Healthcare | $69M | 0.00% |
278ASPS | ALTISOURCE PORTFOLIO SOLUTIONS SA | Real Estate | $63M | 0.00% |
279OPXS | OPTEX SYSTEMS HOLDINGS INC | Industrials | $60M | 0.00% |
280XLO | XILIO THERAPEUTICS INC | Healthcare | $58M | 0.00% |
281TZOO | TRAVELZOO | Communication Services | $53M | 0.00% |
282COCH | ENVOY MEDICAL INC | Healthcare | $53M | 0.00% |
283YARW | YARROW BIOSCIENCE INC | Healthcare | $52M | 0.00% |
284ELOX | ELOXX PHARMACEUTICALS INC | Healthcare | $52M | 0.00% |
Full long-leg book as of November 2026 · cap-weighted · total market cap $4.21T. Hypothetical model holdings — not a registered fund’s portfolio.
Size × value map of the long-leg book
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Days required to liquidate the largest position at 20% of one day's dollar volume.
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20261113T032607 rows=2198308 asof=202611 issuers=20261113T063725 rates=20261113T063725
Measured on the 2026-11 formation date across 284 holdings (cap-weighted). A different formation date can produce different verdicts.
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 335 monthly observations · about 3.4 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 17.3% | 4.1% |
| 3 yearsp.a. | 20.3% | 4.0% |
| 5 yearsp.a. | 8.3% | 4.6% |
| 10 yearsp.a. | 15.3% | 5.0% |
| Since inceptionp.a. | 9.2% | 1.3% |
| Year | Long leg | Long-short |
|---|---|---|
| 202611 mo | 15.3% | 1.5% |
| 2025 | 18.3% | 24.6% |
| 2024 | 18.8% | -10.2% |
| 2023 | 25.7% | 13.4% |
| 2022 | -30.8% | -6.0% |
| 2021 | 38.9% | 4.1% |
| 2020 | 30.8% | 14.6% |
| 2019 | 25.3% | -3.9% |
| 2018 | 6.9% | 19.4% |
| 2017 | 20.1% | 0.3% |
| 2016 | 5.0% | -2.0% |
| 2015 | 0.9% | -2.8% |
| 2014 | 18.4% | -2.4% |
| 2013 | 37.6% | 5.7% |
| 2012 | 16.9% | -4.0% |
| 2011 | -4.4% | -15.6% |
| 2010 | 17.3% | 7.3% |
| 2009 | 32.6% | -0.9% |
| 2008 | -43.1% | -17.3% |
| 2007 | 17.0% | 7.1% |
| 2006 | 17.8% | 10.1% |
| 2005 | 23.1% | 17.4% |
| 2004 | 5.8% | -12.9% |
| 2003 | 35.6% | 0.7% |
| 2002 | -27.4% | -0.9% |
| 2001 | -13.5% | 22.4% |
| 2000 | -20.1% | -2.0% |
| 1999 | 34.5% | -15.3% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through November 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
The Foundry Net Operating Assets Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a Net Operating Assets signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,140-name universe at November 2026. Rows: Large ≥ $5.3B, Small < $832M. Columns: Value ≥ 0.62, Growth < 0.33 B/M. The dot marks the capital-weighted centroid of the book — 97% toward Large, 83% toward Growth. +4% unclassified (42 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → November 2026; the right-hand end is the same value as the box’s dot. 284 names now. Hypothetical holdings — descriptive, not P&L.